Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy

Abstract

Intravitreal administration of 1.25 mg bevacizumab at the time of cataract surgery was safe and effective in preventing the progression of DR and diabetic maculopathy in patients with cataract and DR.